Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

RCUS

Arcus Biosciences Inc

Dec 13 • 04:00PM ET

16.08

Dollar change -1.08
Percentage change -6.29	%

Healthcare • Biotechnology • USA • NYSE

Peers: BMY MRK PFE JNJ GILD ABBV NVS LLY REGN VRTX

| Held by: IJR IWM VTI XBI VXF VB SPSM IWO IBB VBK

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.15	Insider Own	47.38%	Shs Outstand	91.50M	Perf Week	-7.00%
Market Cap	1.38B	Forward P/E	-	EPS next Y	-4.33	Insider Trans	-0.00%	Shs Float	48.15M	Perf Month	-2.13%
Income	-270.00M	PEG	-	EPS next Q	-1.25	Inst Own	54.49%	Short Float	16.68%	Perf Quarter	-4.85%
Sales	263.00M	P/S	5.24	EPS this Y	19.56%	Inst Trans	2.63%	Short Ratio	10.88	Perf Half Y	-5.24%
Book/sh	6.17	P/B	2.60	EPS next Y	-29.80%	ROA	-22.10%	Short Interest	8.03M	Perf Year	-6.73%
Cash/sh	12.70	P/C	1.27	EPS next 5Y	7.80%	ROE	-49.77%	52W Range	13.52 - 20.31	Perf YTD	-15.81%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.70%	ROI	-44.12%	52W High	-20.83%	Beta	0.85
Dividend TTM	-	Quick Ratio	5.23	Sales past 5Y	164.80%	Gross Margin	95.44%	52W Low	18.93%	ATR (14)	1.00
Dividend Ex-Date	-	Current Ratio	5.23	EPS Y/Y TTM	21.18%	Oper. Margin	-113.31%	RSI (14)	47.14	Volatility	5.43% 6.28%
Employees	577	Debt/Eq	0.10	Sales Y/Y TTM	119.80%	Profit Margin	-102.66%	Recom	1.64	Target Price	32.80
Option/Short	Yes / Yes	LT Debt/Eq	0.08	EPS Q/Q	-5.77%	Payout	-	Rel Volume	1.08	Prev Close	17.16
Sales Surprise	23.23%	EPS Surprise	5.33%	Sales Q/Q	50.00%	Earnings	Nov 06 AMC	Avg Volume	738.06K	Price	16.08
SMA20	0.56%	SMA50	-2.85%	SMA200	-1.40%	Trades		Volume	793,801	Change	-6.29%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-24	Initiated	H.C. Wainwright	Neutral	$20
Oct-08-24	Initiated	Wells Fargo	Overweight	$29
Nov-18-22	Initiated	BofA Securities	Neutral	$33
Oct-11-22	Initiated	Morgan Stanley	Overweight	$40
Oct-15-21	Resumed	BTIG Research	Buy	$57
Nov-24-20	Initiated	Berenberg	Buy	$50
Nov-23-20	Initiated	Evercore ISI	Outperform
Apr-03-20	Initiated	Cantor Fitzgerald	Overweight	$21
Mar-04-20	Initiated	Barclays	Overweight	$24
Nov-12-19	Initiated	SunTrust	Buy	$20
Sep-27-19	Initiated	Mizuho	Buy	$22
May-24-19	Resumed	Citigroup	Buy	$25
Oct-09-18	Initiated	Wedbush	Outperform	$22
Apr-09-18	Initiated	Leerink Partners	Outperform	$21
Apr-09-18	Initiated	Goldman	Neutral	$18
Apr-09-18	Initiated	Citigroup	Buy	$18

Show Previous Ratings

Dec-10-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Dec-03-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Dec-02-24 10:18AM	Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend (PR Newswire)
Nov-19-24 04:05PM	Arcus Biosciences to Participate in Two Upcoming Investor Conferences (Business Wire)
Nov-12-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire) -5.52%
02:26AM	Loading…
Nov-07-24 02:26AM	Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... (GuruFocus.com)
Nov-06-24 05:35PM	Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update (Business Wire)
Nov-05-24 09:00AM	Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer (Business Wire)
07:48AM	What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings (GuruFocus.com)
Oct-30-24 10:01AM	Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:00AM	Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting (Business Wire)
Oct-24-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire) -8.47%
07:30AM	First Clinical Data for Arcus Biosciences HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer (Business Wire)
Oct-22-24 04:05PM	Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update (Business Wire)
03:02PM	Loading…
Oct-17-24 03:02PM	State Street Corp's Strategic Adjustment in Arcus Biosciences Holdings (GuruFocus.com)
Oct-09-24 06:03PM	Arcus Biosciences Inc (RCUS) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid ... (GuruFocus.com)
04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
08:00AM	Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium (Business Wire)
Oct-02-24 04:05PM	Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma (Business Wire)
Sep-24-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-10-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Aug-28-24 02:33PM	Arcus Biosciences obtains loan facility with Hercules Capital worth $250m (Pharmaceutical Technology)
Aug-27-24 04:05PM	Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital (Business Wire)
Aug-26-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Aug-21-24 04:05PM	Arcus Biosciences to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-16-24 04:52AM	Nuntius partners with Taiho to develop mRNA cancer therapies (Pharmaceutical Technology)
Aug-08-24 06:15PM	Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +14.02%
04:05PM	Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update (Business Wire)
Aug-01-24 10:01AM	Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
08:00AM	Loading…
08:00AM	Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors (GlobeNewswire)
Jul-25-24 04:05PM	Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update (Business Wire) +5.54%
Jul-09-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
06:32AM	Taiho exercises option for Arcus Biosciences quemliclustat in Asia (Pharmaceutical Technology)
Jul-08-24 06:00PM	Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia (Business Wire)
Jun-25-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jun-11-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jun-10-24 08:30AM	Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers (Business Wire)
Jun-07-24 10:55AM	Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock? (Zacks)
Jun-06-24 04:05PM	Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
Jun-02-24 08:00AM	Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer (Business Wire)
Jun-01-24 08:00AM	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers (Business Wire)
May-24-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
May-10-24 01:38PM	Arcus Biosciences Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
May-09-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire) +5.83%
03:48PM	Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:47AM	Arcus Biosciences Inc (RCUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-08-24 09:59PM	RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:45PM	Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update (Business Wire)
May-02-24 04:05PM	Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024 (Business Wire)
May-01-24 10:01AM	Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-24-24 04:00PM	Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting (Business Wire)
Apr-23-24 04:05PM	Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update (Business Wire) +5.59%
Apr-09-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Mar-29-24 07:01PM	Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS) (GuruFocus.com)
Mar-26-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire) +9.37%
Mar-20-24 07:00PM	Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS) (GuruFocus.com)
Mar-11-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire) +5.67%
Feb-29-24 03:14AM	Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS) (GuruFocus.com)
Feb-28-24 04:05PM	Arcus Biosciences to Participate in Two Upcoming Investor Conferences (Business Wire) -5.10%
Feb-27-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Feb-22-24 11:10AM	Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript (Insider Monkey) +19.87%
09:55AM	Wall Street Analysts Think Arcus Biosciences, Inc. (RCUS) Could Surge 151.61%: Read This Before Placing a Bet (Zacks)
07:16AM	Q4 2023 Arcus Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:37PM	Arcus Biosciences Inc (RCUS) Reports Fourth-Quarter and Full-Year 2023 Financial Results (GuruFocus.com)
04:05PM	Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update (Business Wire)
Feb-09-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Feb-07-24 05:00PM	Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates (Business Wire)
Feb-05-24 12:59PM	Hedge Fund and Insider Trading News: Bill Ackman, Ken Griffin, Paul Tudor Jones, Julian Robertson, Charles Edwards, Arcus Biosciences, Inc. (RCUS), Arrivent Biopharma Inc (AVBP), and More (Insider Monkey)
Jan-29-24 05:00PM	Gilead and Arcus Announce Amended Collaboration and Equity Investment (Business Wire)
Jan-26-24 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jan-16-24 05:00PM	Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Nave Metastatic Pancreatic Cancer (Business Wire)
Dec-11-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Dec-04-23 08:00AM	Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma (Business Wire)
Nov-27-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Nov-14-23 04:00PM	Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference (Business Wire) +7.15%
Nov-13-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Nov-08-23 04:05PM	Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript (Insider Monkey) -14.18%
Nov-07-23 04:01PM	Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update (Business Wire) +5.65%
Nov-06-23 05:00PM	Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers (Business Wire)
Oct-31-23 10:01AM	Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks) +5.08%
Oct-24-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Oct-17-23 04:00PM	Arcus Biosciences to Present Data from Ongoing EDGE-Gastric Study at ASCO Plenary and to Report Third-Quarter Financial Results on November 7 (Business Wire)
Oct-10-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-27-23 05:14AM	Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Sep-26-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-11-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-05-23 07:37PM	Arcus Biosciences (RCUS): A Modestly Undervalued Gem? (GuruFocus.com)
Aug-24-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
11:30AM	Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak (Zacks)
09:02AM	Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study (Zacks)
Aug-23-23 11:39AM	Arcus Biosciences: A Modestly Undervalued Opportunity? (GuruFocus.com) +22.43%
09:00AM	Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences (Business Wire)
Aug-09-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Aug-07-23 09:15AM	Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update (Business Wire)
Aug-03-23 05:55PM	Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-02-23 05:25PM	Allogene Therapeutics (ALLO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-01-23 05:45PM	Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Azoy Alexander	Chief Accounting Officer	Dec 02 '24	Sale	15.32	201	3,079	19,070	Dec 04 04:10 PM
Azoy Alexander	Chief Accounting Officer	Aug 13 '24	Sale	14.97	1,357	20,314	19,070	Aug 15 04:45 PM
Jarrett Jennifer	Chief Operating Officer	Mar 27 '24	Sale	17.55	11,551	202,720	215,253	Mar 29 04:20 PM
Jarrett Jennifer	Chief Operating Officer	Mar 18 '24	Sale	17.92	13,449	240,941	226,804	Mar 20 04:19 PM
Jarrett Jennifer	Chief Operating Officer	Feb 27 '24	Sale	20.11	34,070	685,148	240,253	Feb 28 07:55 PM
Jarrett Jennifer	Chief Operating Officer	Feb 26 '24	Sale	20.07	24,555	492,819	274,323	Feb 28 07:55 PM
Jaen Juan C.	President	Feb 27 '24	Sale	20.10	23,132	464,953	1,188,233	Feb 28 07:55 PM
Jaen Juan C.	President	Feb 26 '24	Sale	20.06	3,900	78,234	1,211,365	Feb 28 07:55 PM
GILEAD SCIENCES, INC.	10% Owner	Jan 29 '24	Buy	21.00	15,238,095	319,999,995	30,061,124	Jan 31 05:00 PM
Goeltz II Robert C.	Chief Financial Officer	Jan 02 '24	Sale	20.00	2,004	40,080	51,831	Jan 04 05:23 PM
Jaen Juan C.	President	Jan 02 '24	Sale	20.09	6,975	140,128	1,215,265	Jan 04 05:22 PM
Jarrett Jennifer	Chief Operating Officer	Dec 22 '23	Sale	17.76	21,521	382,213	258,878	Dec 26 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RCUS

Arcus Biosciences Inc

Upgrade your FINVIZ experience